Expanding consumption of oats beyond the usual breakfast bowl of porridge is the aim of a $5.6 million project at the Food and Beverage Accelerator.
9 May 2025
Researchers at FaBA have developed a toolkit to help manufacturers improve the texture of products to be more appealing to consumers.
3 April 2025University of Queensland researchers have secured 28 grants totalling more than $29 million to address critical health challenges.
18 December 2024
A spider venom molecule being investigated by a University of Queensland team has met critical benchmarks towards becoming a treatment for heart attack and stroke.
17 January 2024The University of Queensland researchers and start-ups have won 4 out of 6 awards at the prestigious Life Sciences Queensland (LSQ) GENE Awards.
17 November 2023
Australian beef producers could lead the world by developing ‘flavour profiles’ for premium products similar to those used in the wine industry, according to a leading UQ researcher.
24 August 2023
A company launched from The University of Queensland’s Institute for Molecular Bioscience (IMB) has passed an important milestone in developing an oral treatment for the common skin disease psoriasis.
15 March 2023
A potentially life-saving treatment containing venom from one of the world’s deadliest spiders is one step closer to human trials, thanks to a $23 million investment in a Brisbane startup.
4 July 2022
The unique flavour, texture and aroma of Australia’s famous Wagyu beef can now be marketed using a world-first flavour profile developed by The University of Queensland in partnership with the Australian Agricultural Company (AACo).
9 August 2020
An Indigenous fruit which is one of the earliest known plant foods eaten in Australia could be the next big thing in the bush foods industry.
31 May 2020
Research into global health issues has been boosted after UQ received more than $29.7 million in funding from the NHMRC and Medical Research Future Fund.
29 August 2019.jpg?itok=mqcCRg-W "Protagonist Therapeutics founder Associate Professor Mark Smythe")
Two companies founded on University of Queensland research have won acclaim at the National AusBiotech Conference in Melbourne.
31 October 2016
University of Queensland spin-out biotech company Protagonist Therapeutics Inc is a step closer to developing a new drug that would benefit millions of people worldwide.
22 August 2016
University of Queensland researchers are developing a new asthma treatment that targets the underlying cause of asthma, rather than just the symptoms.
4 May 2015
An industry-backed centre dedicated to creating healthier food choices for Australian and Asian consumers opened at UQ this week.
17 October 2014
It will soon be possible to grow premium-quality caffeine-free coffee, tea and cocoa, thanks to research involving University of Queensland expertise.
4 September 2014
The University of Queensland has been awarded more than $26 million for health and medical research, to investigate cancer treatments, pain relief, dengue fever vaccinations and more.
18 February 2014The University of Queensland-based Protagonist Therapeutics, Inc. has announced the completion of a $14 million Series B venture financing initiative.
10 July 2013A successful Brisbane biotechnology company formed by The University of Queensland’s Institute for Molecular Bioscience (IMB) is expanding its collaboration with a publicly traded pharmaceutical company based on the east coast of the United States.
10 December 2012
Cutting-edge research that aims to stop the transformation of healthy cells into cancerous cells is one of nine prestigious grants and scholarships awarded to health and medical researchers at The University of Queensland (UQ).
15 December 2011- 1 of 2
- next ›
